The final approval has been received by OCT for starting the clinical trial

11 March 2008

The final approval has been received by OCT for starting the project in Crohn's Disease in the Ukraine for a big Pharmaceutical company, 6 sites, 40 patients.

OCT Vision

“OCT vision is to be recognized by pharmaceutical and biotech companies as a leading provider of clinical trials in Russia, Ukraine, Bulgaria, Belarus, Latvia, Lithuania, Estonia, Poland and Czech Republic. OCT is able to support any requirements that clients may have in the region, ranging from one-off advice to full-study implementation and execution. We are determined and decisive in expanding our activity at this rapidly growing market”— Dmitry Sharov, General Manager of OCT.